Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
The vaccine is the first mRNA vaccine against C. difficile and would be the first vaccine in general to successfully ward off the bacterial infection.
Read storyA study tackles the question of how multiple bacterial species coexist in biofilms.
Researchers have developed a new prognostic evaluation method for sepsis patients using a microfluidic concentration gradient chip.
CDC and PEPFAR have awarded $27.5 million to the Center for Global Health Practice and Impact (CGHPI) at Georgetown University Medical Center to expand its ongoing work in Haiti to address HIV/AIDS.
A compound derived from a plant fungus effectively kills colorectal cancer cells by attacking the enzyme DCTPP1, which thus may serve as a potential biomarker for colorectal cancer and a therapeutic target.
Researchers have carried out the first study in Spain on the use of DoxyPEP as a preventive strategy among the gay, bisexual and other men who have sex with men (GBHSH) community in Spain.
The key to better understanding the spread of infectious diseases may lie where the humanities and the health sciences meet.
Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers at Karolinska Institutet and others. According to the researchers, Sweden is the first country in the world to achieve these targets.
Researchers have used artificial intelligence (AI) to help identify antibiotic-resistant bacteria. The team is the first to investigate how GPT-4, a powerful AI model developed by OpenAI, can be used to analyze antibiotic resistance.
On 16 October, the Ministry of Public Health of Lebanon confirmed a cholera case. Authorities are investigating the extent of the disease’s spread, gathering samples from the patient’s contacts, and assessing potential water contamination.
A research team has set itself the goal of finding natural products that can be used to treat non-infectious diseases by directly searching the bacteria that colonize humans and animals and play a role in the development of diseases.
MpoxVax AFRIVAC is a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox outbreak in the Democratic Republic of Congo (DRC) and surrounding countries.
Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new research.
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV (respiratory syncytial virus) vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 ...
Scientists have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons.
A collaborative study introduces a novel method for identifying the crucial set of gut microbes commonly found in humans and essential for health.
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the fetus for 66% of pregnancies.
Researchers will use tissue-on-chip technology to understand and treat neurological symptoms such as brain fog associated with respiratory diseases like influenza.
A distinct variant of Helicobacter pylori, which arose hundreds of thousands of years ago and spread around the world with us, shows that the genetic variation found in the bacteria in our stomachs today can reveal what our ancestors ate.
In the first study of its kind, researchers found that problems with gut bacteria and related metabolites can help explain the link between ’forever chemicals’ and kidney damage.
Food poisoning microbe Providencia rustigianii, isolated from pediatric gastroenteritis patients, has undergone whole genome sequencing, revealing that it possesses a virulence factor called the type III secretion system.
Scientists exploring how combinations of antibiotics can fight resistant bacteria have been awarded an $11.8 million grant for work that could help save the tens of thousands of lives lost yearly to infections that are increasingly plaguing humanity.
A study has uncovered the genetic nuances of the cpb2 gene in Clostridium perfringens, a bacterium responsible for intestinal infections. The research indicates that cpb2 may enhance the bacterium’s persistence in swine.